Catalyst Crew Technologies Corp. (OTC: CCTC) has unveiled PulmoAI, an artificial intelligence-enabled module designed to support the detection and predictive analysis of pulmonary diseases. The announcement, made on April 7, 2026, positions the platform as a tool to assist healthcare providers in analyzing respiratory health data and identifying potential clinical risks through AI-driven analytics.
PulmoAI is being developed to integrate multiple data inputs, including computed tomography (CT) scans, chest X-rays, pulmonary function tests, and inflammatory biomarkers. The platform is intended to generate structured outputs to support clinical review and care coordination. According to the company, PulmoAI will function as a specialized module within Catalyst Crew's broader digital health ecosystem, which includes its healthcare services coordination platform.
The development of PulmoAI reflects the company's strategy to deploy modular AI systems across telehealth services, remote diagnostics, and technology-enabled healthcare delivery environments. Catalyst Crew Technologies intends to prioritize market development in Latin America, where AI-enabled healthcare technologies may help expand access to respiratory diagnostics and improve healthcare system efficiency.
Dr. Kevin Rodan Levy, CEO of Catalyst Crew Technologies, stated: "Artificial intelligence has the potential to enhance how healthcare providers detect and monitor pulmonary conditions, particularly in environments where access to specialized diagnostics may be limited. PulmoAI reflects our commitment to building scalable, technology-driven solutions to support healthcare delivery."
The company plans to continue developing and refining PulmoAI while evaluating opportunities for pilot programs, strategic partnerships, and phased market deployment. More information is available on the company's website at https://catalystcrewai.com and through its filings with the U.S. Securities and Exchange Commission at www.sec.gov.
Catalyst Crew Technologies is an AI-driven healthcare technology company focused on developing scalable digital health solutions for emerging markets, with an initial emphasis on Latin America. The company is executing a strategic transition into AI-enabled healthcare, pursuing opportunities across telehealth infrastructure, remote patient monitoring, healthcare data analytics, and integrated digital care platforms.
